ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation

AI-based platform, ‘Ask Oscar™’, to accelerate adoption of ENvue’s Navigation Platform and enable clinicians to train independently and reduce implementation barriers

ENvue Medical (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today introduced ‘Ask Oscar™’, a new AI-powered training platform designed to address one of the biggest barriers to adoption of medical technology: training. The platform extends ENvue’s core navigation technology with an AI-powered training layer, designed to accelerate adoption and support future applications, such as the Company’s patent-pending robotic feeding tube solution, ENvue Drive.

AI Capabilities Can Accelerate Revenue

By enabling nurses, dietitians and other clinicians to train on their own schedule, ENvue believes Ask Oscar can significantly accelerate implementation of the ENvue Navigation Platform across both existing and prospective customer accounts.

Importantly, Ask Oscar is expected to be commercially available within the coming months and will be offered across ENvue’s growing installed customer base, creating a scalable recurring revenue opportunity for the Company.

“We believe that Ask Oscar changes the economics of how we scale and opens a new, recurring revenue stream across our existing and prospective hospital customers,” said Doron Besser, Chief Executive Officer of ENvue Medical.

Also Read: AiThority Interview with Matej Bukovinski, Chief Technology Officer at Nutrient

Ask Oscar Addresses a Major Healthcare Barrier: Training

“One of the biggest barriers to scaling any medical technology is training,” said Doron Besser, Chief Executive Officer of ENvue.

Training remains one of the most significant bottlenecks in healthcare technology implementation as hospitals contend with increasing staffing pressures, growing workloads and ongoing challenges coordinating training across multiple shifts and clinical departments. Ask Oscar was developed to help hospitals support nurses, dietitians and other clinicians through training, skill reinforcement and procedural practice by providing real-time guidance and feedback whenever and wherever training is needed – without the need for on-site specialists.

Built upon ENvue’s existing navigation and training infrastructure, Ask Oscar allows clinicians to practice, reinforce and improve feeding tube placement skills through an interactive training environment that provides real-time guidance and objective performance feedback.

The platform continuously monitors user performance during training sessions, detects procedural deviations and provides immediate corrective guidance. Clinicians can practice repeatedly at their own pace without requiring a clinical educator to be physically present during every training session, helping hospitals standardize training, reduce implementation barriers and accelerate adoption.

Foundational Technology that Goes Beyond Training

While the immediate objective is to help clinicians learn faster and help hospitals implement ENvue more efficiently, the Company believes the technology foundation behind Ask Oscar extends beyond training.

Every training session performed within Ask Oscar is measured, analyzed and transformed into actionable feedback. By digitizing and understanding the feeding tube placement procedure itself, the Company believes that Ask Oscar establishes an intelligence layer that can support future applications across the ENvue ecosystem.

This includes technologies associated with ENvue Drive, the Company’s previously announced robotic-assisted feeding tube placement initiative. While Ask Oscar’s first application is training and adoption acceleration, the underlying platform creates opportunities for future intelligent guidance, advanced procedural assistance and robotic-assisted applications.

The launch of Ask Oscar follows the recent publication of an independent peer-reviewed study in Critical Care Nurse demonstrating significant clinical and operational benefits associated with the ENvue Navigation Platform, including zero lung placements across 531 consecutive procedures, a 67% reduction in ventilator-associated pneumonia, a 4,320% increase in post-pyloric feeding access, more than 350 nursing hours freed annually and over $1.5 million in annual cost avoidance within a single health system.

Together, ENvue’s growing body of clinical evidence and Ask Oscar’s ability to support scalable training create a powerful framework for accelerating adoption across hospital systems.

See ‘Ask Oscar’ in action:

ENvue has released a video demonstration showing Ask Oscar guiding a simulated training procedure in real time. The video demonstrates how the platform can provide consistent, on-demand training support wherever training is needed.

ENvue Medical, Inc. (NASDAQ: FEED) is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. Headquartered in Tyler, Texas, with research and development in Tel-Aviv and Nesher, Israel, the Company focuses on two distinct technology platforms:

• ENvue™ Navigation Platform, developed and operated by ENvue Medical Inc., with offices in Arlington Heights, Illinois, and Tel-Aviv, Israel, is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. FDA 510(k) cleared for adult use, ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Future platform expansion may include pediatric and vascular access applications.
• ENvue Medical aims to advance standards in non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation across a range of healthcare environments.
• Acoustic-based therapeutic technologies, including PainShield® and UroShield®, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms.

Also Read: ​​AI systems – Interoperable AI systems: Connecting models across platforms